Clinical Study

The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up

Table 3

Worst acute toxicity at 2 weeks post concurrent RT ( 𝑛 = 2 3 ).

SkinMucosa

RTOG
Acute toxicity grade
 1142
 271
 320
 400

Total233